Biosimilars in a sentence

According to a recent report, more than 40 biosimilars are under development, including approximately 20 biosimilars ready to be released into the market, and a significant number of biosimilars are in the pipeline.

This report studies the global Biosimilars of Monoclonal Antibody market status and forecast, categorizes the global Biosimilars of Monoclonal Antibody market size (value and volume) by manufacturers, type, application, and region.

He also believes the deal will help drive adjusted-earnings growth over the next five years, which is crucial considering how Humira biosimilars will likely create a drag on earnings for several years.

And really trying to understand this, there was a big promise over the last few years that biosimilars are going to be really big for PBMs, et cetera, and we didn't really see that in '23.

Beginning in 2023, five years after their European counterparts, patients in the United States prescribed the autoimmune disease treatment Humira could finally choose from lower-priced biosimilars.

The Affordable Care Act created a pathway for biosimilars to enter the market and compete that is kind of like what we do for generics, but not exactly.

The Hyderabad-based firm is adopting a two-pronged approach to biosimilars by developing innovative products as well as contract manufacturing.

Roche continues: 'Pfizer's recently launched oncology biosimilars - such as Ruxience (rituximab), which launched this quarter - have boosted its revenue and market performance.

This, in turn, should streamline the development of biosimilars and thus accelerate delivery of safe, effective, and affordable biosimilar treatments to patients.

We’d see with the fact that we’ve got, seven to nine biosimilars coming in at 2023 with Amgen coming in at the end of January and the rest coming in, mid-year, we’ve assumed also there’ll be two interchangeables, at least in our planning assumptions.

Also, biosimilars from I&I are very similar because the I&I, they are giving for very extensive period of time, so you need to switch.

Do you agree with the provincial government’s decision to switch from biologic prescription drugs to the cheaper biosimilars?

Dr Reddy’s Laboratories Ltd has bagged `API Supplier of the Year’ award at recently held 6th Annual Global Generics & Biosimilars Awards in Frankfurt, Germany.

The key factors propelling the growth of the rheumatoid arthritis drugs market are the launch of new biosimilars, rising prevalence of arthritis and an increase in the acceptance of biopharmaceuticals.

Increase in the prevalence of prostate cancer and robust development of biosimilars by manufacturers to ensure affordable treatment to the patients is also a major factor to drive growth of the prostate cancer therapeutics market.

Many Asian companies have biosimilars molecules under development, such as LG Life Sciences, Samsung Bioepis, and Celtrion.

This is the fourth product that Mylan will be bringing to market in the area of complex generics and biosimilars, and we're proud to be a leader in the market formation.